PHARM

Pharming Group NV (PHARM)

Pharming Group NV

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:EU:PHARM

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/08	14 : 00	GlobeNewswire Inc.	Pharming Group reports first quarter 2024 financial results and provides business update	EU:PHARM	Pharming Group NV
2024/05/08	14 : 00	GlobeNewswire Inc.	Pharming Group reports first quarter 2024 financial results and provides business update	EU:PHARM	Pharming Group NV
2024/04/24	15 : 00	GlobeNewswire Inc.	Pharming Group to report first quarter 2024 financial results on May 8	EU:PHARM	Pharming Group NV
2024/04/24	14 : 00	GlobeNewswire Inc.	Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards	EU:PHARM	Pharming Group NV
2024/04/24	14 : 00	GlobeNewswire Inc.	Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards	EU:PHARM	Pharming Group NV
2024/04/20	01 : 43	GlobeNewswire Inc.	Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025	EU:PHARM	Pharming Group NV
2024/04/18	22 : 04	GlobeNewswire Inc.	Pharming Group announces the placement of €100 million convertible bonds due 2029	EU:PHARM	Pharming Group NV
2024/04/18	15 : 00	GlobeNewswire Inc.	Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025	EU:PHARM	Pharming Group NV
2024/04/08	14 : 00	GlobeNewswire Inc.	Pharming announces completion of enrollment in pediatric clinical trial of leniolisib	EU:PHARM	Pharming Group NV
2024/04/08	14 : 00	GlobeNewswire Inc.	Pharming announces completion of enrollment in pediatric clinical trial of leniolisib	EU:PHARM	Pharming Group NV
2024/04/04	15 : 30	GlobeNewswire Inc.	Pharming Group announces the 2024 Annual General Meeting of Shareholders	EU:PHARM	Pharming Group NV
2024/04/04	14 : 00	GlobeNewswire Inc.	Pharming Group announces the filing of its 2023 Annual Report and Form 20-F	EU:PHARM	Pharming Group NV
2024/04/03	15 : 00	GlobeNewswire Inc.	Pharming Group to participate in April investor conferences	EU:PHARM	Pharming Group NV
2024/04/03	15 : 00	GlobeNewswire Inc.	Pharming Group to participate in April investor conferences	EU:PHARM	Pharming Group NV
2024/03/14	15 : 00	GlobeNewswire Inc.	Pharming Group reports fourth quarter and full year 2023 financial results	EU:PHARM	Pharming Group NV
2024/02/29	16 : 00	GlobeNewswire Inc.	Pharming Group to report fourth quarter and full year 2023 financial results on March 14	EU:PHARM	Pharming Group NV
2024/02/29	16 : 00	GlobeNewswire Inc.	Pharming Group to report fourth quarter and full year 2023 financial results on March 14	EU:PHARM	Pharming Group NV
2024/02/08	16 : 00	GlobeNewswire Inc.	Pharming Group to participate in February investor conferences	EU:PHARM	Pharming Group NV
2024/02/08	16 : 00	GlobeNewswire Inc.	Pharming Group to participate in February investor conferences	EU:PHARM	Pharming Group NV
2024/01/08	15 : 00	GlobeNewswire Inc.	Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update	EU:PHARM	Pharming Group NV
2024/01/08	15 : 00	GlobeNewswire Inc.	Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update	EU:PHARM	Pharming Group NV
2023/12/13	15 : 00	GlobeNewswire Inc.	Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)	EU:PHARM	Pharming Group NV
2023/11/21	15 : 00	GlobeNewswire Inc.	Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib	EU:PHARM	Pharming Group NV
2023/11/21	15 : 00	GlobeNewswire Inc.	Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib	EU:PHARM	Pharming Group NV
2023/11/10	22 : 51	GlobeNewswire Inc.	Pharming Group provides updates on EMA regulatory review of leniolisib MAA and plans to file for UK regulatory approval	EU:PHARM	Pharming Group NV
2023/11/01	16 : 00	GlobeNewswire Inc.	Pharming Group to participate in November investor conferences	EU:PHARM	Pharming Group NV
2023/11/01	16 : 00	GlobeNewswire Inc.	Pharming Group to participate in November investor conferences	EU:PHARM	Pharming Group NV
2023/10/26	14 : 00	GlobeNewswire Inc.	Pharming Group reports third quarter 2023 financial results	EU:PHARM	Pharming Group NV
2023/10/12	15 : 00	GlobeNewswire Inc.	Pharming Group to report third quarter 2023 financial results on October 26	EU:PHARM	Pharming Group NV
2023/10/12	15 : 00	GlobeNewswire Inc.	Pharming Group to report third quarter 2023 financial results on October 26	EU:PHARM	Pharming Group NV